Inactive Instrument

Press Releases ARCA BIO Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

25/04	ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
19/04	North American Morning Briefing : Stock Futures -2-	DJ

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka	05/06	PR
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	11/05	BU
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	26/04	AQ
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	10/04	PR
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	05/04	BU
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	03/04	PR
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	03/04	BU
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	03/04	AQ
ARCA biopharma Announces 2023 Financial Results	02/02	AQ
ARCA biopharma Announces Third Quarter 2023 Financial Results	19/23/19	AQ
ARCA biopharma announces Second Quarter 2023 Financial Results	24/23/24	AQ
ARCA biopharma Announces Second Quarter 2023 Financial Results	22/23/22	AQ
ARCA biopharma : Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options - Form 8-K	25/23/25	PU
ARCA BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	25/23/25	AQ
ARCA biopharma Announces First Quarter 2023 Financial Results	25/23/25	AQ
ARCA BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	25/23/25	AQ
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update	27/23/27	AQ
ARCA biopharma : Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options - Form 8-K	25/23/25	PU
ARCA BIOPHARMA, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	25/23/25	AQ
ARCA BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	25/23/25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ARCA BIO Nasdaq

Equities

Press Releases

Filters